Multiple myeloma (MM) is an incurable malignancy, and despite novel anti-myeloma drugs that increased survival, up to 30% of patients develop primary resistance, and many patients experience early relapse. Multiple myeloma (MM) is a malignancy characterized by expansion of plasma ... Read more

A novel method of preventing secondary infections, by inhibition of membrane type I matrix-metalloproteinase-1, which reduces degradation of the extra cellular matrix. Pathogens that infect the respiratory system are the cause of some of the most dangerous infections, especially ... Read more